Search

everythinglearnresearchcommunity

for

Search:↓

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

The substances improved hair regrowth and protected hair cells in humans and mice.

Retinoids may help treat lupus nephritis and reduce steroid use.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Combining low-level laser therapy with scalp microneedling and a clobetasol solution significantly improves androgenetic alopecia.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Deltsid 7.5 is the most effective treatment for bovine psoroptosis.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Both 0.01% and 0.03% bimatoprost safely improve eyebrow fullness, with a patient preference for the 0.03% concentration.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Tazarotene gel may be more effective for acne than adapalene gel.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

Trilostane helped a dog with an adrenal tumor feel better and stay healthy.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.